Predicting spike protein NTD mutations of SARS-CoV-2 causing immune evasion by molecular dynamics simulations. Issue 5 (24th January 2022)

• Record Type: Journal Article
• Authors: Zhou, Liping; Wu, Leyun; Peng, Cheng; Yang, Yanqing; Shi, Yulong; Gong, Likun; Xu, Zhijian; Zhu, Weiliang
• Is Part Of: Physical chemistry chemical physics. Volume 24:Issue 5(2022)
• Page Start: 3410
• Page End: 3419
• Publication Date: 2022-01-24
• Subjects: Chemistry, Physical and theoretical -- Periodicals; 541.3
• DOI: 10.1039/d1cp05059a
• Languages: English
• ISSNs: 1463-9076

Abstract

Abstract : Some NTD residues including R246, Y144, K147, Y248, L249 and P251 have high risks for immune evasion from NTD-specific monoclonal antibodies, among which R246 is the most significant. Abstract : The coronavirus disease 2019 (COVID-19) pandemic was caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Among all the potential targets studied for developing drugs and antibodies, the spike (S) protein is the most striking one, which is on the surface of the virus. In contrast with the intensively investigated immunodominant receptor-binding domain (RBD) of the protein, little is known about the neutralizing antibody binding mechanisms of the N-terminal domain (NTD), let alone the effects of NTD mutations on antibody binding and thereby the risk of immune evasion. Based on 400 ns molecular dynamics simulation for 11 NTD–antibody complexes together with other computational approaches in this study, we investigated critical residues for NTD–antibody binding and their detailed mechanisms. The results show that 36 residues on the NTD including R246, Y144, K147, Y248, L249 and P251 are critically involved in the direct interaction of the NTD with many monoclonal antibodies (mAbs), indicating that the viruses harboring these residue mutations may have a high risk of immune evasion. Binding free energy calculations and an interaction mechanism study reveal that R246I, which is present in the Beta (B.1.351/501Y.V2) variant, may have various impacts on current NTD antibodies through abolishing the hydrogen bonds and electrostatic interaction with the antibodies or affecting other interface residues. Therefore, special attention should be paid to the mutations of these key residues in future antibody and vaccine design and development.